Blood News and Research

RSS

Starting anti-HIV treatment early improves survival among patients with newly diagnosed TB

Starting anti-HIV treatment within two weeks of the diagnosis of tuberculosis, or TB, improved survival among patients with both infections who had very low immune-cell counts, according to an analysis by researchers at the University of Pittsburgh Graduate School of Health.

10 Jul 2015

Research: Jumping genes may be responsible for genetic chaos behind oesophageal cancer cases

CANCER RESEARCH UK scientists have found that 'jumping genes' may add to the genetic chaos behind more than three-quarters of oesophageal cancer cases, according to research published in BMC Genomics today (Friday).

10 Jul 2015

Derby Teaching Hospitals implements Welch Allyn’s FlexiPort blood pressure cuff system

Caring staff at Derby Teaching Hospitals NHS Foundation Trust, currently featuring in a new ITV hospital documentary ‘Superhospital’ have been demonstrating their star qualities to an audience of millions.

10 Jul 2015

University of Liverpool researchers discover common cause of cardiac injury in sepsis patients

Researchers at the University of Liverpool's Institute of Infection and Global Health (IGH) have discovered a common cause of heart damage in patients with sepsis.

10 Jul 2015

New guidelines seek to protect athletes from exercise-associated hyponatremia

While the risks of dehydration are well known, new international guidelines seek to protect athletes from the serious health risks associated with drinking too many fluids while exercising.

10 Jul 2015

Recently-developed drug holds great promise for children with acute lymphoblastic leukaemia

A new Australian study shows that a recently-developed drug, already used safely in adult leukaemia clinical trials, holds great promise for some children with an aggressive form of cancer known as acute lymphoblastic leukaemia (ALL).

10 Jul 2015

Globavir agrees to exclusively license novel oncology compound to Sorrento Therapeutics

Globavir Biosciences, Inc., a specialty biotechnology company developing small molecule drugs to treat cancer and infectious diseases, and Sorrento Therapeutics, Inc., an oncology company developing new treatments for cancer and associated pain, announced today that the companies have entered into an agreement under which Globavir exclusively licensed its novel oncology compound, BC001, to Sorrento Therapeutics.

9 Jul 2015

FDA approves new heart failure drug

A new drug called Entresto has been approved by the U.S Food and Drug Administration (FDA) for the treatment of heart failure.

9 Jul 2015

Penn State Hershey cardiologist explains causes and symptoms of heart attack

It's possible to have a heart attack and not even know it. Maybe it's because you're stoic when it comes to pain and fatigue. Or maybe you write off your symptoms as heartburn or indigestion. It's even possible that your own body is kicking up its reserves to mask symptoms of what is happening inside.

9 Jul 2015

Up-to-date treatment and diagnostic guidelines for diabetic retinal degeneration

Around 600,000 Austrians suffer from diabetes. This condition is frequently associated with serious retinal disorders. Along with age-related macular degeneration, diabetic retinal degeneration is one of the most common causes of blindness. The Department of Ophthalmology and Optometry at MedUni Vienna was chosen by the European Society of Retina Specialists (EURETINA) to coordinate the development of up-to-date treatment and diagnostic guidelines.

9 Jul 2015

Visual and narrative arts can help physicians hone their observational skills

The visual and narrative arts can help physicians hone their observational skills — a critical expertise increasingly needed in today's medicine, contends a Georgetown University Medical Center family medicine professor.

9 Jul 2015

AMGF announces results, impact of Measure Up/Pressure Down campaign

The American Medical Group Foundation today announced the results and impact of its second annual Measure Up/Pressure Down National Day of Action: Roll Up Your Sleeves! event. On May 7, during National High Blood Pressure Education Month, more than 140 campaign supporters across the country took an "action" for blood pressure control - including blood pressure screenings, materials dissemination, social media posts, web chats, website content updates, employee trainings, health fairs, and garnering media coverage - reaching 84.3 million Americans.

9 Jul 2015

New study finds that secondhand smoke increases risk of stroke for nonsmokers

Nearly 800,000 people in the U.S. suffer a stroke each year. Stroke is responsible for one out of every 19 deaths in the U.S. and it is a leading cause of disability. A new study published in the American Journal of Preventive Medicine found that secondhand smoke (SHS) increases the risk of stroke by about 30 percent for nonsmokers.

9 Jul 2015

UC San Diego, GSK collaborate to treat leukemia by eliminating cancer stem cells

Researchers at the University of California, San Diego School of Medicine and Moores Cancer Center are working with GSK on a bench-to-bedside project to treat leukemia and other diseases by eliminating cancer stem cells. The collaboration is part of GSK's Discovery Partnerships with Academia (DPAc) program, where academic partners become core members of drug-hunting teams.

9 Jul 2015

Researchers find way to measure the aging process in young adults

An international research team from the US, UK, Israel and New Zealand has found a way to measure the aging process in young adults -- a younger population than is usually tested in aging studies.

9 Jul 2015

Diabetes and high blood sugar impose negative effect on cognitive, decision-making skills

MINNEAPOLIS - In just two years, people with type 2 diabetes experienced negative changes in their ability to regulate blood flow in the brain, which was associated with lower scores on tests of cognition skills and their ability to perform their daily activities, according to a new study published in the July 8, 2015, online issue of Neurology, the medical journal of the American Academy of Neurology.

9 Jul 2015

Vanderbilt investigators develop potential antibody treatments against chikungunya

In late 2013 the Caribbean had its first case of the mosquito-borne chikungunya virus. Today there have been almost 1.2 million cases in 44 countries or territories, including 177 cases in 31 U.S. States. Vanderbilt University Medical Center's James Crowe, M.D., Ann Scott Carell Professor and director of the Vanderbilt Vaccine Center, and his team are reporting the first large panel of antibody treatments against this disease in the current issue of Cell Host and Microbe.

9 Jul 2015

International consensus panel reviews new diagnostic criteria for neuromyelitis optica spectrum disorder

New diagnostic criteria were introduced this week for neuromyelitis optica, now called neuromyelitis optica spectrum disorder, which is an inflammatory disease of the central nervous system that is sometimes mistaken for multiple sclerosis.

9 Jul 2015

NSU cancer researcher selected for prestigious J. William Fulbright award

Nova Southeastern University cancer researcher Appu Rathinavelu, Ph.D., was selected for a prestigious J. William Fulbright award to conduct cancer research and training in India. Dr. Rathinavelu is associate dean for institutional planning and development at NSU's College of Pharmacy and executive director of NSU's Rumbaugh-Goodwin Institute for Cancer Research.

9 Jul 2015

Mayo Clinic awarded $11 million NCI grant to study survivorship in patients with non-Hodgkin lymphoma

Mayo Clinic announced today that it has received a five-year, $11 million grant from the National Cancer Institute to study survivorship in patients with non-Hodgkin lymphoma (NHL). The Lymphoma Epidemiology of Outcomes Cohort Study will enroll 12,000 patients with NHL. The study will follow these patients for long-term prognosis and survivorship.

9 Jul 2015

Blood News and Research

Starting anti-HIV treatment early improves survival among patients with newly diagnosed TB

Research: Jumping genes may be responsible for genetic chaos behind oesophageal cancer cases

Derby Teaching Hospitals implements Welch Allyn’s FlexiPort blood pressure cuff system

University of Liverpool researchers discover common cause of cardiac injury in sepsis patients

New guidelines seek to protect athletes from exercise-associated hyponatremia

Recently-developed drug holds great promise for children with acute lymphoblastic leukaemia

Globavir agrees to exclusively license novel oncology compound to Sorrento Therapeutics

FDA approves new heart failure drug

Penn State Hershey cardiologist explains causes and symptoms of heart attack

Up-to-date treatment and diagnostic guidelines for diabetic retinal degeneration

Visual and narrative arts can help physicians hone their observational skills

AMGF announces results, impact of Measure Up/Pressure Down campaign

New study finds that secondhand smoke increases risk of stroke for nonsmokers

UC San Diego, GSK collaborate to treat leukemia by eliminating cancer stem cells

Researchers find way to measure the aging process in young adults

Diabetes and high blood sugar impose negative effect on cognitive, decision-making skills

Vanderbilt investigators develop potential antibody treatments against chikungunya

International consensus panel reviews new diagnostic criteria for neuromyelitis optica spectrum disorder

NSU cancer researcher selected for prestigious J. William Fulbright award

Mayo Clinic awarded $11 million NCI grant to study survivorship in patients with non-Hodgkin lymphoma

Industry Focus eBook - Forensics & toxicology (2nd edition) eBook

Improving healthcare sustainability through carbon data

Managing vibration in IVF laboratories

A New Approach to Preventing Bladder Cancer Recurrence

Latest News